BLCA prognostic model creation and validation based on immune gene-metabolic gene combination.

Background: Bladder cancer (BLCA) is a prevalent urinary system malignancy. Understanding the interplay of immunological and metabolic genes in BLCA is crucial for prognosis and treatment.

Methods: Immune/metabolism genes were extracted, their expression profiles analyzed.